price
IR
NASDAQ · IRWD
Ironwood Pharmaceuticals, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$4.31
Up+$0.23 (+5.64%)
Updated Aug 15, 2026, 6:44 AM
SID Score
6.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 598.66M
- P/E ratio
- 7.07
- Dividend yield
- 0.00%
- 52-week range
- $3.02 – $4.88
- Volume
- 2.33M
- Avg. volume
- 2.12M
Price performance
IRWD price history
1M range · 21 trading sessions · Daily adjusted prices
IRWD closed at $4.31 after 21 trading sessions, up 11.66% for the selected period.
- Last close
- $4.31
- Period change
- +11.66%
- Period low
- $3.56
- Period high
- $4.42
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $4.03 | $4.35 | $3.96 | $4.31 | 2.33M |
| Aug 13, 2026 | $4.41 | $4.41 | $4.05 | $4.08 | 2.08M |
| Aug 12, 2026 | $4.32 | $4.505 | $4.255 | $4.32 | 2.72M |
| Aug 11, 2026 | $4.08 | $4.315 | $4.06 | $4.30 | 1.93M |
| Aug 10, 2026 | $4.17 | $4.275 | $4.04 | $4.05 | 2.18M |
| Aug 7, 2026 | $4.30 | $4.40 | $4.21 | $4.32 | 1.84M |
| Aug 6, 2026 | $4.16 | $4.375 | $3.92 | $4.26 | 3.36M |
| Aug 5, 2026 | $4.34 | $4.425 | $4.13 | $4.15 | 2.21M |
| Aug 4, 2026 | $4.53 | $4.57 | $4.275 | $4.31 | 5.77M |
| Aug 3, 2026 | $4.325 | $4.59 | $4.28 | $4.42 | 3.82M |
| Jul 31, 2026 | $3.93 | $4.275 | $3.87 | $4.23 | 3.58M |
| Jul 30, 2026 | $3.60 | $3.76 | $3.55 | $3.73 | 1.3M |
| Jul 29, 2026 | $3.80 | $3.9563 | $3.55 | $3.56 | 1.25M |
| Jul 28, 2026 | $3.90 | $3.97 | $3.76 | $3.80 | 1.82M |
| Jul 27, 2026 | $3.71 | $3.99 | $3.6868 | $3.91 | 1.93M |
| Jul 24, 2026 | $3.79 | $3.84 | $3.70 | $3.71 | 1.11M |
| Jul 23, 2026 | $3.77 | $3.84 | $3.76 | $3.79 | 1.08M |
| Jul 22, 2026 | $3.89 | $3.925 | $3.845 | $3.88 | 1.05M |
| Jul 21, 2026 | $3.87 | $3.92 | $3.81 | $3.91 | 1.16M |
| Jul 20, 2026 | $3.92 | $4.02 | $3.84 | $3.85 | 1.8M |
| Jul 17, 2026 | $3.83 | $4.01 | $3.8046 | $3.86 | 1.8M |
Latest IRWD news
The latest Smart Investors Daily articles mentioning IRWD.
Stock researchResearch & News · News
Loading stock research…